Home » FDA Takes Aim at Two Integra Units in Form 483s
FDA Takes Aim at Two Integra Units in Form 483s
Integra subsidiary Theken Spine was handed a Form 483 for failure to submit 11 of 35 complaints involving products made at its Akron, Ohio, facility. Another five complaints were not submitted within the required 30 day time frame, and 14 complaints associated with corrective actions were never reported to the FDA.
The GMP Letter
The GMP Letter
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May